Consonance Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,998
Closed -$706K 7
2022
Q2
$706K Sell
2,998
-21,565
-88% -$5.08M 2.98% 4
2022
Q1
$4.41M Sell
24,563
-35,275
-59% -$6.33M 7.48% 6
2021
Q4
$12.9M Sell
59,838
-98,000
-62% -$21.2M 8.43% 5
2021
Q3
$29.1M Sell
157,838
-1,249
-0.8% -$231K 15.95% 3
2021
Q2
$28.5M Sell
159,087
-399,075
-71% -$71.6M 3.44% 9
2021
Q1
$93.4M Buy
558,162
+29,198
+6% +$4.88M 9.95% 1
2020
Q4
$80.3M Buy
+528,964
New +$80.3M 7.5% 1
2020
Q2
Sell
-1,350,360
Closed -$128M 37
2020
Q1
$128M Buy
1,350,360
+431,097
+47% +$40.9M 9.53% 2
2019
Q4
$81M Sell
919,263
-48,306
-5% -$4.25M 4.94% 5
2019
Q3
$77.2M Buy
967,569
+196,800
+26% +$15.7M 7.64% 3
2019
Q2
$60.2M Sell
770,769
-454,618
-37% -$35.5M 4.26% 7
2019
Q1
$144M Buy
1,225,387
+124,790
+11% +$14.6M 9.08% 2
2018
Q4
$120M Buy
1,100,597
+238,302
+28% +$26M 8.81% 5
2018
Q3
$110M Buy
862,295
+295,369
+52% +$37.8M 5.94% 3
2018
Q2
$64.1M Hold
566,926
4.14% 11
2018
Q1
$63.7M Buy
+566,926
New +$63.7M 5.82% 6
2017
Q2
Sell
-642,168
Closed -$86.9M 23
2017
Q1
$86.9M Buy
642,168
+61,467
+11% +$8.32M 9.11% 2
2016
Q4
$83.3M Sell
580,701
-237,999
-29% -$34.1M 9.15% 3
2016
Q3
$96.7M Buy
818,700
+400,000
+96% +$47.2M 9.31% 4
2016
Q2
$44.3M Buy
+418,700
New +$44.3M 6.28% 9
2015
Q3
Sell
-387,186
Closed -$67.4M 32
2015
Q2
$67.4M Sell
387,186
-325,000
-46% -$56.5M 6.77% 6
2015
Q1
$123M Buy
712,186
+52,000
+8% +$8.97M 11.18% 1
2014
Q4
$85.5M Sell
660,186
-101,576
-13% -$13.2M 11.01% 2
2014
Q3
$98M Buy
761,762
+334,972
+78% +$43.1M 13.45% 1
2014
Q2
$37.8M Sell
426,790
-242,900
-36% -$21.5M 5.62% 5
2014
Q1
$63M Buy
669,690
+91,000
+16% +$8.56M 9.37% 1
2013
Q4
$65.4M Buy
578,690
+110,500
+24% +$12.5M 10.73% 1
2013
Q3
$36.9M Buy
468,190
+60,024
+15% +$4.73M 9.23% 2
2013
Q2
$26.9M Buy
+408,166
New +$26.9M 9.55% 3